Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Understanding the Alterations in Coagulation Factor Levels in Patients With End Stage Liver Disease

NCT06014320 is registered in ClinicalTrials.gov with Stanford University as lead sponsor.

NCT NCT06014320
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06014320 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Understanding the Alterations in Coagulation Factor Levels in Patients With End Stage Liver Disease
Lead sponsor
Stanford University
Phase
Observational
Overall status
Unknown status
Start date
October 1, 2023
Completion date
October 1, 2024
Enrollment
25 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

coagulation factor deficiency, hemophilia, hemophilia a, hemophilia b, liver cirrhosis, liver failure, liver transplant disorder